Works matching IS 02704137 AND DT 2006 AND VI 66 AND IP 14

Results: 5

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyS. Lilly Zheng and Wennuan Liu contributed equally to the study.
Published in:
Prostate, 2006, v. 66, n. 14, p. 1556, doi. 10.1002/pros.20496
By:
- S. Lilly Zheng;
- Wennuan Liu;
- Fredrik Wiklund;
- Latchezar Dimitrov;
- Katarina Bälter;
- Jielin Sun;
- Hans‐Olov Adami;
- Jan‐Erik Johansson;
- Jishan Sun;
- Baoli Chang;
- Matthew Loza;
- Aubrey R. Turner;
- Eugene R. Bleecker;
- Deborah A. Meyers;
- John D. Carpten;
- David Duggan;
- William B. Isaacs;
- Jianfeng Xu;
- Henrik Grönberg
Publication type:
Article
Identification of both Myt‐1 and Wee‐1 as necessary mediators of the p21‐independent inactivation of the cdc‐2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein.
Published in:
Prostate, 2006, v. 66, n. 14, p. 1542, doi. 10.1002/pros.20495
By:
- Lara H. El Touny;
- Partha P. Banerjee
Publication type:
Article
Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Gγ/T‐15 transgenic mouse model of prostate cancer.
Published in:
Prostate, 2006, v. 66, n. 14, p. 1487, doi. 10.1002/pros.20478
By:
- Teresita Reiner;
- Alicia de las Pozas;
- Carlos Perez‐Stable
Publication type:
Article
ACTR/AIB1/SRC‐3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
Published in:
Prostate, 2006, v. 66, n. 14, p. 1474, doi. 10.1002/pros.20477
By:
- June X. Zou;
- Zhenyu Zhong;
- Xu‐Bao Shi;
- Clifford G. Tepper;
- Ralph W. deVere White;
- Hsing‐Jien Kung;
- Hongwu Chen
Publication type:
Article
Auto‐antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3.
Published in:
Prostate, 2006, v. 66, n. 14, p. 1463, doi. 10.1002/pros.20439
By:
- E.R. Pontes;
- L.C. Matos;
- E.A. da Silva;
- L.S. Xavier;
- B.L. Diaz;
- I.A. Small;
- E.M. Reis;
- S. Verjovski‐Almeida;
- M.A. Barcinski;
- E.R.P. Gimba
Publication type:
Article

Works matching IS 02704137 AND DT 2006 AND VI 66 AND IP 14

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyS. Lilly Zheng and Wennuan Liu contributed equally to the study.

Identification of both Myt‐1 and Wee‐1 as necessary mediators of the p21‐independent inactivation of the cdc‐2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein.

Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Gγ/T‐15 transgenic mouse model of prostate cancer.

ACTR/AIB1/SRC‐3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.

Auto‐antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3.